Procedures: To assess the relationship between Manganese Enhanced Magnetic Resonance 27 Imaging (MEMRI) and the expression of calcium receptors in human prostate and breast cancer 28 animal models.
The pseudometastatic prostate cancer animal models, obtained by intra-cardiac injection of 173 PC3 cells, developed multiple lesions in the mediastinum, liver and peritoneal deposits with the SE of all the metastatic deposits (SI range from -0.9 to 47% (see table 1 ). Different Several studies demonstrated the important role of calcium channels in carcinogenesis and in 221 the modulation of cancer progression by inducing high metastatic risk (33-36). Thus, it was 222 deemed important to explore the use of non-invasive imaging methods, to better investigate 223 these receptors and their relationship with cancer development.
224
In our previous study, we applied MEMRI to image breast cancer tumours with a high- Ca 2+ -selective channel and therefore quite distinguishable especially in Ca 2+ -related 230 intracellular pathways. 231 We used MDA-MB-231 breast and PC3 prostate cancer cell lines normally expressing 232 both CaSR and TRPV6 at high levels (data not shown). However, in in vivo cancer animal 233 models, these tumour cells displayed different expression levels (score 0-4) for both calcium 234 receptors. Different manganese uptake was observed in the corresponding MR images.
235
Orthotopic human breast tumours showed either absence (score from 0) or high-level 236 expression (score 4) of both receptors at the immunohistochemistry analysis, while in the 237 orthotopic human prostate tumours both receptors were low expressed or absent (score 0-1).
238
Manganese uptake appeared well correlated with the level of expression of both receptors 239 ( Figure 1 and 2). 
254
Metastatic cancer animal models are very challenging due to the reproducibility of 255 invasiveness of the models; moreover, they showed to recapitulate the intra and inter-tumour 256 heterogeneity usually observed in human metastatic tumours (bone and visceral metastases).
257
We developed intraosseous human breast cancer animal models (for bone metastasis) and It is worth of notice that the two mice with metastatic prostate cancer developed visceral 266 metastases at very different rates. The mouse progressed quickly only immunohistochemistry 267 was performed (supplementary data 1). MEMRI was performed on the second mouse and 268 heterogeneous manganese uptake in all the visceral metastatic deposits was observed with a 269 SE% that ranged from -0.9 to 47%. In this case the expression level of CaSR and TRPV6 270 receptors was markedly different, instead of what observed for the other cancer animal models.
271
TRPV6 was highly expressed in most of the metastatic deposits with a score 4 ( Figure 4) showed good manganese uptake with a SE% of 33-47%.
277
Overall, as shown in Fig.6 , the obtained results suggest a potential link between CaSR 278 and manganese uptake. Manganese ions are analogues of calcium ions and cellular uptake of 279 the two ions is expected to occur through the same mechanism(s) (40). However, we observed 280 ( Fig.6) demonstrated that manganese uptake was correlated with cancer cell proliferation (41). 313 However, in this study calcium receptors expression level was not investigated.
314
The mechanism behind CaSR expression and activation is the result of a very complex 315 combination of multi-receptor actions that affect the entire cellular calcium metabolism and 316 thus, also cancer cell proliferation. The level of extracellular calcium concentration is 317 responsible of the activation of different intra and intercellular pathways which may affect the 318 tumour microenvironment and, thus, the manganese uptake.
319
A potential limitation of this study is a control group to explore the "active role" of 320 calcium receptors on manganese uptake by using in vivo calcium blockers, as we have specific MR protocol was applied to the cancer animal models, as previously described (15); 397 see Table 1 for MR details parameters.
